Yongmei Ding

Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients

Yajun Zhang, Zhiwei Zhang, Yongmei Ding et al. · Journal of Cancer Research and Clinical Oncology · 2021 · 137 citations · Full text

Cell Therapy, Medicine, Immune Checkpoint Inhibitor +8

Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice

He Li, Yao Huang, Duqing Jiang et al. · Cell Death and Disease · 2018 · 105 citations · Full text

Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes

Shuyan Meng, Bo Su, Wěi Li et al. · Nanotechnology · 2010 · 61 citations

Novel Dual-targeted Peptide, Drug Targeting, Engineering +15

Integrin-targeted paclitaxel nanoliposomes for tumor therapy

Shuyan Meng, Bo Su, Wěi Li et al. · Medical Oncology · 2010 · 52 citations

Nanomedicine, Drug Targeting, Integrin-targeted Paclitaxel Nanoliposomes +3

Novel sodium lignosulphonate assisted synthesis of well dispersed Fe3O4 microspheres for efficient adsorption of copper (II)

Yingying Wang, Xiaohong Wang, Yongmei Ding et al. · Powder Technology · 2017 · 42 citations

Materials Science, Extractive Metallurgy, Chemical Engineering +9